欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
AT/H/0943/003
药品名称
Atorvastatin 40 mg film-coated tablets
活性成分
atorvastatin calcium salt 40.0 mg
剂型
Film-coated tablet
上市许可持有人
TEVA Pharma B.V.
参考成员国 - 产品名称
Austria (AT)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
Atorvastatin 40 mg film-coated tablets
Denmark (DK)
Belgium (BE)
Netherlands (NL)
Atorvastatine Teva 40 mg, filmomhulde tabletten
Ireland (IE)
France (FR)
Portugal (PT)
Italy (IT)
Sweden (SE)
Norway (NO)
Finland (FI)
Lithuania (LT)
Atorvastatin Teva 40mg plėvele dengtos tabletės
Estonia (EE)
Bulgaria (BG)
Czechia (CZ)
Slovakia (SK)
许可日期
2010/07/06
最近更新日期
2023/10/04
药物ATC编码
C10AA05 atorvastatin
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final PL
|
final_PL_AT_H_0943_IA_056_G_clean
Date of last change:2023/05/16
Final SPC
|
final_SmPC_AT_H_0943_IA_056_G_clean
Date of last change:2023/05/16
Final Labelling
|
final_common_LAB_AT_H_0943_001-004_IB_054_clean
Date of last change:2021/12/23
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase